YCP-30437-45315
4 vaccinations
16 coded responses
29 check-ins
15 free-text entries
8 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 970 / OR
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Registered in v-safe
-
2021-03-19
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-03-30
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-06
- 2021-04-08
- 2021-04-15
- 2021-04-23
- 2021-04-29
-
2021-05-06
Survey response — day 35, dose 2MedDRA: Decreased appetite, Nausea — Feeling: FairFree text: I'm nauseous and my appetite is poor.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
-
2021-07-06
Survey response — 3 months, dose 2MedDRA: Rash — Feeling: PoorFree text: RashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-11
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Survey response — 6 months, dose 2MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Discovered I had Hep B in my past. My MS symptoms have worsened.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — day 21, dose 3MedDRA: Fatigue, Office visit, Parosmia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Increased fatigue and a weird odor in my nose. · Healthcare visit (other): Med office visit.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Report sent to call center — day 21, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-15
-
2021-10-17
Survey response — day 35, dose 3MedDRA: Hepatitis B, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: DX w/Hep B. · Healthcare visit (other): Labs and doctor. And HepAB vax.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-17
Report sent to call center — day 35, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-10-19
- 2021-11-03
-
2022-03-12
Survey response — 6 months, dose 3MedDRA: Peripheral arterial occlusive disease, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: PAD · Healthcare visit (other): ImagingMedDRA releases: 2024-11 · check-in free text available
-
2022-03-12
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-14
Call successfulCompleted over the phone
-
2022-04-15
Dose 4 — Pfizer-BioNTech
-
2022-04-17
Survey response — days 1–6 daily, dose 4MedDRA: Aortic arteriosclerosis, Peripheral arterial occlusive disease — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: New dx of left leg artery w/plaque and in my heart.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Survey response — days 1–6 daily, dose 4MedDRA: Fatigue — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: RundownMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Survey response — days 1–6 daily, dose 4MedDRA: Fatigue — Feeling: Poor · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: I'm exhausted today!MedDRA releases: 2024-11 · check-in free text available
-
2022-04-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-22
Health check-in — day 7, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-29
Survey response — day 14, dose 4MedDRA: Abdominal pain upper, Myalgia, Pruritus — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stomach hurts, still itching, muscle achesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Survey response — day 21, dose 4MedDRA: Fatigue, Haemorrhage, Thrombosis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Heavy bleeding w/clots. I don't know where from. It started suddenly and I bled for about 20 min. faster than I could clean the floor! I'm exhausted today.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Survey response — day 28, dose 4MedDRA: Office visit, Rectal haemorrhage, Sinusitis, Vaginal haemorrhage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Bleeding w/clots from my rectum or vagina! Sinus infection. · Healthcare visit (other): Labs, urine test, apptMedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — day 28, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-05-16
-
2022-05-17
Call successfulCompleted over the phone
-
2022-05-17
Call successfulCompleted over the phone
-
2022-05-17
Call successfulCompleted over the phone
- 2022-05-20
-
2022-05-27
Survey response — day 42, dose 4MedDRA: Haemorrhage, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Bleeding excessively from either my bladder or rectum. · Healthcare visit (other): UltrasoundMedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-01
-
2022-07-15
Survey response — 3 months, dose 4MedDRA: COVID-19, Rectal haemorrhage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Rectal bleeding, COVID and the aftermath of it!MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-14
Survey response — 6 months, dose 4MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Long COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-17
-
2023-04-17
Survey response — 12 months, dose 4MedDRA: Office visit, Post-acute COVID-19 syndrome — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-17
Report sent to call center — 12 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-04-19
- 2023-04-19
-
2023-05-17
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-09-11 | Pfizer-BioNTech | No |
| 4 | 2022-04-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-06 | Successful 2022-05-17 |
Completed over the phone |
| 2021-10-17 | Successful 2022-05-17 |
Completed over the phone |
| 2022-03-12 | Successful 2022-03-14 |
Completed over the phone |
| 2022-05-13 | Successful 2022-05-17 |
Completed over the phone |
| 2022-05-27 | Successful 2022-07-18 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-07-15 | Successful 2022-07-18 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-14 | Unsuccessful | Reported to VAERS during previous contact from GDIT |
| 2023-04-17 | Successful 2023-05-17 |
Reported to VAERS during previous contact from GDIT |
Free text
Release 8 — day 35, dose 2
Symptoms: I'm nauseous and my appetite is poor.
Release 9 — 3 months, dose 2
Symptoms: Rash
Release 10 — 6 months, dose 2
Symptoms: Discovered I had Hep B in my past. My MS symptoms have worsened.
Release 10 — day 21, dose 3
Symptoms: Increased fatigue and a weird odor in my nose.
Healthcare visit (other): Med office visit.
Release 10 — day 35, dose 3
Release 11 — 6 months, dose 3
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): New dx of left leg artery w/plaque and in my heart.
Systemic reaction (other): Rundown
Systemic reaction (other): I'm exhausted today!
Release 11 — day 14, dose 4
Symptoms: Stomach hurts, still itching, muscle aches
Release 11 — day 21, dose 4
Symptoms: Heavy bleeding w/clots. I don't know where from. It started suddenly and I bled for about 20 min. faster than I could clean the floor! I'm exhausted today.
Release 11 — day 28, dose 4
Symptoms: Bleeding w/clots from my rectum or vagina! Sinus infection.
Healthcare visit (other): Labs, urine test, appt
Release 11 — day 42, dose 4
Symptoms: Bleeding excessively from either my bladder or rectum.
Healthcare visit (other): Ultrasound
Release 12 — 3 months, dose 4
Symptoms: Rectal bleeding, COVID and the aftermath of it!
Release 12 — 6 months, dose 4
Symptoms: Long COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal pain upper | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Haemorrhage | · | · | ✓ |
| SD | Hepatitis B | · | · | ✓ |
| SD | Multiple sclerosis | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Peripheral arterial occlusive disease | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rectal haemorrhage | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SRO | Aortic arteriosclerosis | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Peripheral arterial occlusive disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release